Abstract
The quality of life of patients treated for brain tumor is, in all cases, deeply altered by the tumor and the treatments. Optimizing the symptomatic management is a key objective for all care givers. We present in this paper a very pragmatic focus concerning the management of intracranial hypertension (and/or neurological deficits), venous thromboembolism, confusion, epilepsy and symptoms more directly associated with the end of life.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Anticoagulants / therapeutic use
-
Brain Neoplasms / complications
-
Brain Neoplasms / physiopathology
-
Brain Neoplasms / psychology
-
Brain Neoplasms / therapy*
-
Confusion / etiology
-
Confusion / psychology
-
Confusion / therapy
-
Epilepsy / etiology
-
Epilepsy / psychology
-
Epilepsy / therapy
-
Humans
-
Intracranial Hypertension / etiology
-
Intracranial Hypertension / therapy
-
Medical Oncology* / ethics
-
Palliative Care
-
Quality of Life
-
Terminal Care
-
Venous Thrombosis / etiology
-
Venous Thrombosis / therapy